436 related articles for article (PubMed ID: 24510515)
41. Control of Heterologous Simian Immunodeficiency Virus SIV
Singh S; Ramírez-Salazar EG; Doueiri R; Valentin A; Rosati M; Hu X; Keele BF; Shen X; Tomaras GD; Ferrari G; LaBranche C; Montefiori DC; Das J; Alter G; Trinh HV; Hamlin C; Rao M; Dayton F; Bear J; Chowdhury B; Alicea C; Lifson JD; Broderick KE; Sardesai NY; Sivananthan SJ; Fox CB; Reed SG; Venzon DJ; Hirsch VM; Pavlakis GN; Felber BK
J Virol; 2018 Aug; 92(15):. PubMed ID: 29793957
[TBL] [Abstract][Full Text] [Related]
42. Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus.
Clements JE; Montelaro RC; Zink MC; Amedee AM; Miller S; Trichel AM; Jagerski B; Hauer D; Martin LN; Bohm RP
J Virol; 1995 May; 69(5):2737-44. PubMed ID: 7707496
[TBL] [Abstract][Full Text] [Related]
43. Good CoP, bad CoP? Interrogating the immune responses to primate lentiviral vaccines.
Klasse PJ; Moore JP
Retrovirology; 2012 Oct; 9():80. PubMed ID: 23025660
[TBL] [Abstract][Full Text] [Related]
44. Immunoprofiling Correlates of Protection Against SHIV Infection in Adjuvanted HIV-1 Pox-Protein Vaccinated Rhesus Macaques.
Lu P; Guerin DJ; Lin S; Chaudhury S; Ackerman ME; Bolton DL; Wallqvist A
Front Immunol; 2021; 12():625030. PubMed ID: 34046030
[TBL] [Abstract][Full Text] [Related]
45. Immunity and protection by live attenuated HIV/SIV vaccines.
Wodarz D
Virology; 2008 Sep; 378(2):299-305. PubMed ID: 18586297
[TBL] [Abstract][Full Text] [Related]
46. DNA Prime-Boost Vaccine Regimen To Increase Breadth, Magnitude, and Cytotoxicity of the Cellular Immune Responses to Subdominant Gag Epitopes of Simian Immunodeficiency Virus and HIV.
Hu X; Valentin A; Dayton F; Kulkarni V; Alicea C; Rosati M; Chowdhury B; Gautam R; Broderick KE; Sardesai NY; Martin MA; Mullins JI; Pavlakis GN; Felber BK
J Immunol; 2016 Nov; 197(10):3999-4013. PubMed ID: 27733554
[TBL] [Abstract][Full Text] [Related]
47. Impact of vaccination on cytotoxic T lymphocyte immunodominance and cooperation against simian immunodeficiency virus replication in rhesus macaques.
Ishii H; Kawada M; Tsukamoto T; Yamamoto H; Matsuoka S; Shiino T; Takeda A; Inoue M; Iida A; Hara H; Shu T; Hasegawa M; Naruse TK; Kimura A; Takiguchi M; Matano T
J Virol; 2012 Jan; 86(2):738-45. PubMed ID: 22072784
[TBL] [Abstract][Full Text] [Related]
48. Live-attenuated lentivirus immunization modulates innate immunity and inflammation while protecting rhesus macaques from vaginal simian immunodeficiency virus challenge.
Genescà M; Ma ZM; Wang Y; Assaf B; Qureshi H; Fritts L; Huang Y; McChesney MB; Miller CJ
J Virol; 2012 Sep; 86(17):9188-200. PubMed ID: 22696662
[TBL] [Abstract][Full Text] [Related]
49. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
[TBL] [Abstract][Full Text] [Related]
50. Towards an AIDS vaccine: the role of nonhuman primates.
Nathanson N; Mathieson BJ
J Med Primatol; 1999; 28(4-5):146-53. PubMed ID: 10593479
[TBL] [Abstract][Full Text] [Related]
51. Acute-phase CD4+ T-cell proliferation and CD152 upregulation predict set-point virus replication in vaccinated simian-human immunodeficiency virus strain 89.6p-infected macaques.
Koopman G; Mortier D; Hofman S; Koutsoukos M; Bogers WMJM; Wahren B; Voss G; Heeney JL
J Gen Virol; 2009 Apr; 90(Pt 4):915-926. PubMed ID: 19223489
[TBL] [Abstract][Full Text] [Related]
52. Determining the immune mechanisms of protection from AIDS: correlates of immunity and the development of syngeneic macaques.
Kent SJ; Ada GL; Hayes E; Lewis IM
Immunol Rev; 2001 Oct; 183():94-108. PubMed ID: 11782250
[TBL] [Abstract][Full Text] [Related]
53. Immunization with recombinant macaque major histocompatibility complex class I and II and human immunodeficiency virus gp140 inhibits simian-human immunodeficiency virus infection in macaques.
Yang GB; Wang Y; Babaahmady K; Schøller J; Rahman D; Bunnik E; Spallek R; Zong CM; Duan JZ; Qin C; Jiang H; Singh M; Vaughan R; Bergmeier LA; Schuitemaker H; Shao Y; Lehner T
J Gen Virol; 2012 Jul; 93(Pt 7):1506-1518. PubMed ID: 22492918
[TBL] [Abstract][Full Text] [Related]
54. Linking pig-tailed macaque major histocompatibility complex class I haplotypes and cytotoxic T lymphocyte escape mutations in simian immunodeficiency virus infection.
Gooneratne SL; Alinejad-Rokny H; Ebrahimi D; Bohn PS; Wiseman RW; O'Connor DH; Davenport MP; Kent SJ
J Virol; 2014 Dec; 88(24):14310-25. PubMed ID: 25275134
[TBL] [Abstract][Full Text] [Related]
55. Attenuated poxvirus-based simian immunodeficiency virus (SIV) vaccines given in infancy partially protect infant and juvenile macaques against repeated oral challenge with virulent SIV.
Van Rompay KK; Abel K; Lawson JR; Singh RP; Schmidt KA; Evans T; Earl P; Harvey D; Franchini G; Tartaglia J; Montefiori D; Hattangadi S; Moss B; Marthas ML
J Acquir Immune Defic Syndr; 2005 Feb; 38(2):124-34. PubMed ID: 15671796
[TBL] [Abstract][Full Text] [Related]
56. Towards an HIV-1 vaccine: lessons from studies in macaque models.
Hulskotte EG; Geretti AM; Osterhaus AD
Vaccine; 1998; 16(9-10):904-15. PubMed ID: 9682336
[TBL] [Abstract][Full Text] [Related]
57. Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells.
Almond N; Kent K; Cranage M; Rud E; Clarke B; Stott EJ
Lancet; 1995 May; 345(8961):1342-4. PubMed ID: 7752758
[TBL] [Abstract][Full Text] [Related]
58. Vaccine-induced plasmablast responses in rhesus macaques: phenotypic characterization and a source for generating antigen-specific monoclonal antibodies.
Silveira EL; Kasturi SP; Kovalenkov Y; Rasheed AU; Yeiser P; Jinnah ZS; Legere TH; Pulendran B; Villinger F; Wrammert J
J Immunol Methods; 2015 Jan; 416():69-83. PubMed ID: 25445326
[TBL] [Abstract][Full Text] [Related]
59. Dominant induction of vaccine antigen-specific cytotoxic T lymphocyte responses after simian immunodeficiency virus challenge.
Takahara Y; Matsuoka S; Kuwano T; Tsukamoto T; Yamamoto H; Ishii H; Nakasone T; Takeda A; Inoue M; Iida A; Hara H; Shu T; Hasegawa M; Sakawaki H; Horiike M; Miura T; Igarashi T; Naruse TK; Kimura A; Matano T
Biochem Biophys Res Commun; 2011 May; 408(4):615-9. PubMed ID: 21531211
[TBL] [Abstract][Full Text] [Related]
60. Simian-Human Immunodeficiency Virus SHIV.CH505 Infection of Rhesus Macaques Results in Persistent Viral Replication and Induces Intestinal Immunopathology.
Bar KJ; Coronado E; Hensley-McBain T; O'Connor MA; Osborn JM; Miller C; Gott TM; Wangari S; Iwayama N; Ahrens CY; Smedley J; Moats C; Lynch RM; Haddad EK; Haigwood NL; Fuller DH; Shaw GM; Klatt NR; Manuzak JA
J Virol; 2019 Sep; 93(18):. PubMed ID: 31217249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
